Home » Newsletters » BioWorld Science

BioWorld Science

March 6, 2003

View Archived Issues

Novel antidiabetic beta3-adrenoceptor agonists covered by Wyeth patent

New inhibitors of SGLT transporters discovered by Kyowa Hakko scientists

Antiallergic peptides presented by Hayashibara and Sankyo researchers

Boehringer Ingelheim prepares and tests series of HCV NS5B inhibitors

NeoTherapeutics describes new agents for neuronal stimulation and regeneration

Novel mGluR antagonists with utility in cerebral infarction and neuropathic pain

Antibacterial quinolizinones in early development at Sato

Mercian claims HMG-CoA-inhibitory mevastatin analogues

New ascorbate-tocopherol adduct with dual activity as elastase inhibitor and free radical scavenger

Novuspharma updates R&D development and clinical progress

Reduced hyperinflammatory response reported after postinjury PolyHeme rescue

IL-2 combined with HAART reported to enhance immune restoration in HIV infection

Versicor and Biosearch Italia complete merger, summarize results for 2002

Avelox approved for CAP pneumonia due to penicillin-resistant S. pneumoniae

CG-53135 cleared to enter phase I trials

Recombinant AAT therapy enters phase I

Priority review granted for Arixtra sNDA

Myoview approved for assessment of left ventricular function

Consistent positive weight loss trends observed in AOD-9604 trial

Phase III protocol for tesmilifene accepted by FDA

New phase II study assesses NS-2330 for advanced Parkinson's disease

Ilex Campath rights broadened to all nononcology therapeutic uses

Synergistic antitumor activity for antiestrogen/FTI combinations in ER-positive breast cancer

Kyorin and Eisai to jointly market rizatriptan for migraine in Japan

BioSante completes menopause phase II/III trial of Bio-E-Gel

Calanolide A combination therapy for HIV completes clinical trial

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 12, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...